Location History:
- Comasco, IT (2013)
- It, IT (2017)
Company Filing History:
Years Active: 2013-2017
Title: Innovations in Pharmaceutical Dosage Forms by Paolo Galfetti
Introduction
Paolo Galfetti is a notable inventor based in Italy, recognized for his contributions to the field of pharmaceutical formulations. With a focus on improving the delivery of active pharmaceutical agents, he holds two patents that showcase his innovative approach. His work has significantly influenced how medications can be administered, making them more effective for patient treatment.
Latest Patents
Galfetti's latest patents include groundbreaking advancements in non-mucoadhesive film dosage forms. These orally disintegrating film dosage forms are designed to deliver active pharmaceutical agents effectively. His methods aim to retard absorption through the oral mucosa, which enhances the therapeutic outcomes for various medical conditions. The innovative approach taken by Galfetti in these patents reflects his commitment to enhancing pharmaceutical technologies.
Career Highlights
Throughout his career, Paolo Galfetti has made substantial contributions to companies like Applied Pharma Research SA and Labtec Corporation. His experience in these organizations has allowed him to refine his skills and push the boundaries of pharmaceutical innovations. His work at these companies has been pivotal in the development of effective drug delivery systems.
Collaborations
Collaboration has been a key aspect of Galfetti's career. He has worked alongside talented colleagues, including Christian Leichs and Armin Breitenbach. Their combined expertise has enabled them to explore new possibilities in pharmaceutical formulations and drug delivery technologies.
Conclusion
Paolo Galfetti stands out as a visionary inventor in the pharmaceutical industry. His patents demonstrate a significant leap forward in the field of dosage forms, making essential contributions to how medications are delivered and absorbed. With continued collaboration and innovation, Galfetti is poised to influence medical treatments for years to come.